Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome


      • Increased secretion of Fetuin A and LBP from adipose tissue of MetS subjects, which correlates with insulin resistance.
      • The study documents increased secretion of DAMP, HMGB1 and increased TLR2 and TLR4 protein in subcutaneous adipose.
      • We demonstrate increased mRNA for Fetuin A, LBP and HMGB1 in mice fat depots and adipocytes.



      Adipose Tissue (AT) dysregulation contributes to the pro-inflammatory state and insulin resistance of Metabolic Syndrome (MetS). We examined AT secretion of the hepatokine, Fetuin-A, LBP, sCD14 and HMGB-1, and toll-like receptor 2 and 4 protein levels in MetS and controls.

      Design and methods

      Secreted levels of Fetuin-A, LBP, HMGB-1 and sCD14 and TLR2 and TLR4 protein in AT of controls and MetS patients were assayed. Also mRNA and protein for Fetuin-A, LBP, sCD14 and HMGB-1 were studied in subcutaneous fat depot of mice and during adipocyte differentiation.


      Secretion of Fetuin-A, LBP and HMGB-1 from AT were significantly increased in MetS (n = 28) compared to controls (n = 25), even after adjustment for adiposity. There were no significant differences in sCD14. Both LBP and Fetuin-A correlated significantly with HOMA-IR and increased significantly with increasing features of MetS. There was a significant increase in AT TLR2 and TLR4 protein in MetS compared to controls. Expression of Fetuin-A and LBP were significantly higher in subcutaneous white adipose tissue of HFD fed mice as well as in ob/ob mice compared to C57BL6/J control mice (n = 6 per group). Additionally mRNA and protein levels of FetA, LBP and HMGB-1 increased during differentiation of 3T3-L1 adipocytes.


      We make the novel observation of increased secretion of Fetuin A, LBP and HMGB-1 from AT and hypothesize that these engage TLRs in AT and other tissues contributing to the pro-inflammatory state and insulin resistance of MetS.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Grundy S.M.
        • Cleeman J.I.
        • Daniels S.R.
        • Donato K.A.
        • Eckel R.H.
        • Franklin B.A.
        • Gordon D.J.
        • Krauss R.M.
        • Savage P.J.
        • Smith Jr., S.C.
        • Spertus J.A.
        • Fernando Costa
        Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary.
        Circulation. 2005; 112: 2735-2752
        • Alberti K.G.
        • Eckel R.H.
        • Grundy S.M.
        • Zimmet P.Z.
        • Cleeman J.I.
        • Donato K.A.
        • Fruchart J.C.
        • James W.P.
        • Loria C.M.
        • Smith Jr., S.C.
        International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.
        Circulation. 2009; 120: 1640-1645
        • Jialal I.
        • Huet B.A.
        • Kaur H.
        • Chien A.
        • Devaraj S.
        Increased toll-like receptor activity in patients with metabolic syndrome.
        Diabetes Care. 2012; 35: 900-904
        • Hardy O.T.
        • Kim A.
        • Ciccarelli C.
        • Hayman L.L.
        • Wiecha J.
        Increased Toll-like receptor (TLR) mRNA expression in monocytes is a feature of metabolic syndrome in adolescents.
        Pediatr. Obes. 2013; 8: e19-23
        • Jialal I.
        • Kaur H.
        • Devaraj S.
        Toll-like receptor status in obesity and metabolic syndrome: a translational perspective.
        J. Clin. Endocrinol. Metab. 2014; 99: 39-48
        • Bremer A.A.
        • Devaraj S.
        • Afify A.
        • Jialal I.
        Adipose tissue dysregulation in patients with metabolic syndrome.
        J. Clin. Endocrinol. Metab. 2011; 96 (7): E1782-E1788
        • Bremer A.A.
        • Jialal I.
        Adipose tissue dysfunction in nascent metabolic syndrome.
        J. Obes. 2013; 2013: 393192
        • Jialal I.
        • Devaraj S.
        • Kaur H.
        • Adams-Huet B.
        • Bremer A.A.
        Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome.
        J. Clin. Endocrinol. Metab. 2013; 98: E514-E517
        • Stefan N.
        • Häring H.U.
        The role of hepatokines in metabolism.
        Nat. Rev. Endocrinol. 2013; 9: 144-152
        • Heinrichsdorff J.
        • Olefsky J.M.
        Fetuin-A: the missing link in lipid-induced inflammation.
        Nat. Med. 2012; 18: 1182-1183
        • Schumann R.R.
        Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule.
        Biochem. Soc. Trans. 2011; 39: 989-993
        • Ix J.H.
        • Wassel C.L.
        • Chertow G.M.
        • Koster A.
        • Johnson K.C.
        • Tylavsky F.A.
        • Cauley J.A.
        • Cummings S.R.
        • Harris T.B.
        • Shlipak M.G.
        Health aging and body composition study. Fetuin-A and change in body composition in older persons.
        J. Clin. Endocrinol. Metab. 2009; 94: 4492-4498
        • Tönjes A.
        • Fasshauer M.
        • Kratzsch J.
        • Stumvoll M.
        • Blüher M.
        Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
        PLoS One. 2010; 5 (9): e13911
        • Trepanowski J.F.
        • Mey J.
        • Varady K.A.
        Fetuin-A: a novel link between obesity and related complications.
        Int. J. Obes. (Lond). 2014; ([Epub ahead of print])
        • Pan Z.
        • Zhou L.
        • Hetherington C.J.
        • Zhang D.E.
        Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes.
        J. Biol. Chem. 2000; 275: 36430-36435
        • Yanai H.
        • Ban T.
        • Taniguchi T.
        High-mobility group box family of proteins: ligand and sensor for innate immunity.
        Trends Immunol. 2012; 33: 633-640
        • Harris H.E.
        • Andersson U.
        • Pisetsky D.S.
        HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.
        Nat. Rev. Rheumatol. 2012; 8: 195-202
        • Ulevitch R.J.
        • Tobias P.S.
        Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.
        Annu Rev. Immunol. 1995; 13: 437-457
        • Lee C.C.
        • Avalos A.M.
        • Ploegh H.L.
        Accessory molecules for Toll-like receptors and their function.
        Nat. Rev. Immunol. 2012; 12: 168-179
        • Pal D.
        • Dasgupta S.
        • Kundu R.
        • Maitra S.
        • Das G.
        • Mukhopadhyay S.
        • Ray S.
        • Majumdar S.S.
        • Bhattacharya S.
        Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance.
        Nat. Med. 2012; 18: 1279-1285
        • Jialal I.
        • Devaraj S.
        • Adams-Huet B.
        • Chen X.
        • Kaur H.
        Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome.
        J. Clin. Endocrinol. Metab. 2012; 97: E1844-E1850
        • Jialal I.
        • Devaraj S.
        • Singh U.
        • Huet B.A.
        Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk.
        Atherosclerosis. 2010; 211: 297-302
        • Jialal I.
        • Rajamani U.
        • Adams-Huet B.
        • Kaur H.
        Circulating pathogen associated molecular pattern – binding proteins and high mobility group box protein 1 in nascent metabolic syndrome: implications for cellular Toll-like receptor activity.
        Atherosclerosis. 2014; 236: 182-187
        • Bakke J.
        • Bettaieb A.
        • Nagata N.
        • Matsuo K.
        • Haj F.G.
        Regulation of the SNARE-interacting protein Munc18c tyrosine phosphorylation in adipocytes by protein-tyrosine phosphatase 1B.
        Cell. Commun. Signal. 2013; 11: 57-64
        • Sun L.
        • Yu Z.
        • Ye X.
        • Zou S.
        • Li H.
        • Yu D.
        • Wu H.
        • Chen Y.
        • Dore J.
        • Clément K.
        • Hu F.B.
        • Lin X.
        A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese.
        Diabetes Care. 2010; 33 (24Pubmed): 1925-1932
        • Moreno-Navarrete J.M.
        • Escoté X.
        • Ortega F.
        • Serino M.
        • Campbell M.
        • Michalski M.C.
        • Laville M.
        • Xifra G.
        • Luche E.
        • Domingo P.
        • Sabater M.
        • Pardo G.
        • Waget A.
        • Salvador J.
        • Giralt M.
        • Rodriguez-Hermosa J.I.
        • Camps M.
        • Kolditz C.I.
        • Viguerie N.
        • Galitzky J.
        • Decaunes P.
        • Ricart W.
        • Frühbeck G.
        • Villarroya F.
        • Mingrone G.
        • Langin D.
        • Zorzano A.
        • Vidal H.
        • Vendrell J.
        • Burcelin R.
        • Vidal-Puig A.
        • Fernández-Real J.M.
        A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction.
        Diabetologia. 2013; 56 (25): 2524-2537
        • Weiss J.
        Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria.
        Biochem. Soc. Trans. 2003; 31 (26): 785-790
        • Ge Q.
        • Gérard J.
        • Noël L.
        • Scroyen I.
        • Brichard S.M.
        MicroRNAs regulated by adiponectin as novel targets for controlling adipose tissue inflammation.
        Endocrinology. 2012; 153: 5285-5296
        • Stefan N.
        • Hennige A.M.
        • Staiger H.
        • Machann J.
        • Schick F.
        • Kröber S.M.
        • Machicao F.
        • Fritsche A.
        • Häring H.U.
        Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.
        Diabetes Care. 2006; 29 (28): 853-857
        • Stefan N.
        • Häring H.U.
        Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans.
        Nat. Med. 2013; 19 (29): 394-395
        • Ix J.H.
        • Shlipak M.G.
        • Brandenburg V.M.
        • Ali S.
        • Ketteler M.
        • Whooley M.A.
        Association between human Fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.
        Circulation. 2006; 113: 1760-1767
      1. Xu Y, Xu M, Bi Y, Song A, Huang Y, Liu Y, Wu Y, Chen Y, Wang W, Li X, Ning G. Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese. Atherosclerosis. double citation.

        • Chatterjee P.
        • Seal S.
        • Mukherjee S.
        • Kundu R.
        • Mukherjee S.
        • Ray S.
        • Mukhopadhyay S.
        • Majumdar S.S.
        • Bhattacharya S.
        Adipocyte fetuin-A contributes to macrophage migration into adipose tissue and polarization of macrophages.
        J. Biol. Chem. 2013; 288: 28324-28330
        • Park J.S.
        • Svetkauskaite D.
        • He Q.
        • Kim J.Y.
        • Strassheim D.
        • Ishizaka A.
        • Abraham E.
        Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.
        J. Biol. Chem. 2004; 279: 7370-7377
        • Guzmán-Ruiz R.
        • Ortega F.
        • Rodríguez A.
        • Vázquez-Martínez R.
        • Díaz-Ruiz A.
        • Garcia-Navarro S.
        • Giralt M.
        • Garcia-Rios A.
        • Cobo-Padilla D.
        • Tinahones F.J.
        • López-Miranda J.
        • Villarroya F.
        • Frühbeck G.
        • Fernández-Real J.M.
        • Malagón M.M.
        Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cells.
        Int. J. Obes. (Lond). 2014 Feb 28;
        • Gunasekaran M.K.
        • Viranaicken W.
        • Girard A.C.
        • Festy F.
        • Cesari M.
        • Roche R.
        • Hoareau L.
        Inflammation triggers high mobility group box 1 (HMGB1) secretion in adipose tissue, a potential link to obesity.
        Cytokine. 2013; 64: 103-111
        • Trepanowski J.F.
        • Mey J.
        • Varady K.A.
        Fetuin-A: a novel link between obesity and related complications.
        Int. J. Obes. (Lond). 2014 Dec 3; ([Epub ahead of print])
        • Moreno-Navarrete J.M.
        • Ortega F.
        • Serino M.
        • Luche E.
        • Waget A.
        • Pardo G.
        • Salvador J.
        • Ricart W.
        • Frühbeck G.
        • Burcelin R.
        • Fernández-Real J.M.
        Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance.
        Int. J. Obes. (Lond). 2012; 36: 1442-1449
        • Yang P.J.
        • Lee W.J.
        • Tseng P.H.
        • Lee P.H.
        • Lin M.T.
        • Yang W.S.
        Bariatric surgery decreased the serum level of an endotoxin-associated marker: lipopolysaccharide-binding protein.
        Surg. Obes. Relat. Dis. 2014; 10: 1182-1187
        • Villar-García J.
        • Hernández J.J.
        • Güerri-Fernández R.
        • González A.
        • Lerma E.
        • Guelar A.
        • Saenz D.
        • Sorlí L.
        • Montero M.
        • Horcajada J.P.
        • Knobel Freud H.
        Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial.
        J. Acquir Immune Defic. Syndr. 2015; 68: 256-263
        • Moutzouri E.
        • Tellis C.C.
        • Rousouli K.
        • Liberopoulos E.N.
        • Milionis H.J.
        • Elisaf M.S.
        • Tselepis A.D.
        Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide – induced cytokine production in monocytes of hypercholesterolemic patients.
        Atherosclerosis. 2012; 225: 381-387